×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LNTH – lantheus holdings, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LNTH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/15
10:48 am
lnth
Lantheus (LNTH) had its price target raised by Truist Financial Corporation from $89.00 to $98.00. They now have a "buy" rating on the stock.
Low
Report
Lantheus (LNTH) had its price target raised by Truist Financial Corporation from $89.00 to $98.00. They now have a "buy" rating on the stock.
4/13
12:08 pm
lnth
Lantheus (LNTH) was given a new $95.00 price target by Mizuho.
Low
Report
Lantheus (LNTH) was given a new $95.00 price target by Mizuho.
4/8
06:18 am
lnth
3 Cash-Producing Stocks Walking a Fine Line [Yahoo! Finance]
Low
Report
3 Cash-Producing Stocks Walking a Fine Line [Yahoo! Finance]
3/20
08:03 pm
lnth
Is Invesco S&P MidCap 400 GARP ETF (GRPM) a Strong ETF Right Now? [Yahoo! Finance]
Low
Report
Is Invesco S&P MidCap 400 GARP ETF (GRPM) a Strong ETF Right Now? [Yahoo! Finance]
3/18
11:46 am
lnth
Lantheus says FDA extended review period for radioactive diagnostic kit [Seeking Alpha]
Low
Report
Lantheus says FDA extended review period for radioactive diagnostic kit [Seeking Alpha]
3/17
07:03 pm
lnth
Lantheus (LNTH) had its "outperform" rating reaffirmed by William Blair.
Low
Report
Lantheus (LNTH) had its "outperform" rating reaffirmed by William Blair.
3/17
04:43 pm
lnth
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) [Yahoo! Finance]
Low
Report
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) [Yahoo! Finance]
3/17
04:39 pm
lnth
US FDA extends review of Lantheus' diagnostic imaging kit by three months [Yahoo! Finance]
Low
Report
US FDA extends review of Lantheus' diagnostic imaging kit by three months [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/27
10:20 am
lnth
Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: VANGUARD GROUP INC
3/20
04:20 pm
lnth
Form ARS Lantheus Holdings, Inc. For: Dec 31
Low
Report
Form ARS Lantheus Holdings, Inc. For: Dec 31
3/20
04:16 pm
lnth
Form DEFA14A Lantheus Holdings, Inc.
Low
Report
Form DEFA14A Lantheus Holdings, Inc.
3/20
04:14 pm
lnth
Form DEF 14A Lantheus Holdings, Inc. For: Apr 30
Low
Report
Form DEF 14A Lantheus Holdings, Inc. For: Apr 30
3/10
05:19 pm
lnth
Form PRE 14A Lantheus Holdings, Inc. For: Apr 30
Low
Report
Form PRE 14A Lantheus Holdings, Inc. For: Apr 30
3/9
05:06 pm
lnth
Form 4 Lantheus Holdings, Inc. For: Mar 05 Filed by: Niedzwiecki Daniel
Medium
Report
Form 4 Lantheus Holdings, Inc. For: Mar 05 Filed by: Niedzwiecki Daniel
3/9
05:06 pm
lnth
Form 4 Lantheus Holdings, Inc. For: Mar 05 Filed by: Dinkelborg Ludger
Medium
Report
Form 4 Lantheus Holdings, Inc. For: Mar 05 Filed by: Dinkelborg Ludger
3/9
05:05 pm
lnth
Form 4 Lantheus Holdings, Inc. For: Mar 05 Filed by: Morgan Amanda Michelle
Medium
Report
Form 4 Lantheus Holdings, Inc. For: Mar 05 Filed by: Morgan Amanda Michelle
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/19
Form EFFECT Lantheus Holdings, Inc.
14.2%
4/6 Form DEFA14A Lantheus Holdings, Inc. 7.3%
3/12 Form DEF 14A Lantheus Holdings, Inc. For: Apr 23 6.7%
10/31 Q3/2019 9/30/2019 EPS 0.280 ZacksConsensus 0.250 ActVsEst 0.030 - Beat 5.1%
4/14 Velan Capital Agrees to Support Merger of Lantheus and Progenics 4.9%
12/17 Form 4 Lantheus Holdings, Inc. For: Dec 13 Filed by: LENO SAM R 4.1%
6/11 Form 4 Lantheus Holdings, Inc. For: Jun 07 Filed by: LENO SAM R 4.0%
2/25 Q4/2019 12/31/2019 EPS 0.340 ZacksConsensus 0.310 ActVsEst 0.030 - Beat 3.6%
9/5 Form 4 Lantheus Holdings, Inc. For: Sep 03 Filed by: Heino Mary Anne 3.2%
10/2 Progenics activist calls buyout deal 'value-destructive' [Seeking Alpha] 3.1%
4/6 Form DEFA14A Lantheus Holdings, Inc. 7.3%
3/12 Form DEF 14A Lantheus Holdings, Inc. For: Apr 23 6.7%
10/31 Q3/2019 9/30/2019 EPS 0.280 ZacksConsensus 0.250 ActVsEst 0.030 - Beat 5.1%
4/14 Velan Capital Agrees to Support Merger of Lantheus and Progenics 4.9%
12/17 Form 4 Lantheus Holdings, Inc. For: Dec 13 Filed by: LENO SAM R 4.1%
6/11 Form 4 Lantheus Holdings, Inc. For: Jun 07 Filed by: LENO SAM R 4.0%
2/25 Q4/2019 12/31/2019 EPS 0.340 ZacksConsensus 0.310 ActVsEst 0.030 - Beat 3.6%
9/5 Form 4 Lantheus Holdings, Inc. For: Sep 03 Filed by: Heino Mary Anne 3.2%
10/2 Progenics activist calls buyout deal 'value-destructive' [Seeking Alpha] 3.1%
TOP News Decliners
10/2
Form 8-K Lantheus Holdings, Inc. For: Oct 01
-20.8%
7/25 Q2/2019 6/30/2019 EPS 0.270 ZacksConsensus 0.270 ActVsEst 0.000 - In-Line -20.4%
3/16 Form S-4/A Lantheus Holdings, Inc. -10.2%
4/30 Form 4 Lantheus Holdings, Inc. For: Apr 28 Filed by: DUFFY MICHAEL P -7.5%
4/15 Lantheus Holdings Inc (NASDAQ: LNTH) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -7.1%
4/30 Form 10-Q Lantheus Holdings, Inc. For: Mar 31 -7.0%
10/4 SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc. -5.9%
1/13 Lantheus Holdings Announces Senior Leadership Appointment -5.8%
2/26 Form 4 Lantheus Holdings, Inc. For: Feb 24 Filed by: Heino Mary Anne -5.8%
7/5 Form 4 Lantheus Holdings, Inc. For: Jul 03 Filed by: MARKISON BRIAN A -4.1%
7/25 Q2/2019 6/30/2019 EPS 0.270 ZacksConsensus 0.270 ActVsEst 0.000 - In-Line -20.4%
3/16 Form S-4/A Lantheus Holdings, Inc. -10.2%
4/30 Form 4 Lantheus Holdings, Inc. For: Apr 28 Filed by: DUFFY MICHAEL P -7.5%
4/15 Lantheus Holdings Inc (NASDAQ: LNTH) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -7.1%
4/30 Form 10-Q Lantheus Holdings, Inc. For: Mar 31 -7.0%
10/4 SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc. -5.9%
1/13 Lantheus Holdings Announces Senior Leadership Appointment -5.8%
2/26 Form 4 Lantheus Holdings, Inc. For: Feb 24 Filed by: Heino Mary Anne -5.8%
7/5 Form 4 Lantheus Holdings, Inc. For: Jul 03 Filed by: MARKISON BRIAN A -4.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: